Pool JL - Search Results

1

Propylbutyldopamine. Mechanism of blood pressure lowering in hypertensive patients.

Taylor AA, Fennell WH, Ruud CO, Pool JL, Nelson EB, Ginos JZ, Mitchell JR. Taylor AA, et al. Among authors: pool jl. Hypertension. 1984 Mar-Apr;6(2 Pt 2):I40-5. doi: 10.1161/01.hyp.6.2_pt_2.i40. Hypertension. 1984. PMID: 6373598 Clinical Trial.

2

Antihypertensive activity of isradipine in humans: a new dihydropyridine calcium channel antagonist.

Nelson EB, Pool JL, Taylor AA. Nelson EB, et al. Among authors: pool jl. Clin Pharmacol Ther. 1986 Dec;40(6):694-7. doi: 10.1038/clpt.1986.246. Clin Pharmacol Ther. 1986. PMID: 2946507 Clinical Trial.

3

Effect of doxazosin monotherapy on blood pressure and plasma lipids in patients with essential hypertension.

Cubeddu LX, Pool JL, Bloomfield R, Klotman PE, Pickering BI, Wombolt DG, Nelson EB, Halperin A. Cubeddu LX, et al. Among authors: pool jl. Am J Hypertens. 1988 Apr;1(2):158-67. doi: 10.1093/ajh/1.2.158. Am J Hypertens. 1988. PMID: 2969740 Clinical Trial.

4

Pharmacokinetics and pharmacodynamics of enalapril in patients with congestive heart failure and patients with hypertension.

Schwartz JB, Taylor A, Abernethy D, O'Meara M, Farmer J, Young J, Nelson E, Pool J, Mitchell JR. Schwartz JB, et al. J Cardiovasc Pharmacol. 1985 Jul-Aug;7(4):767-76. doi: 10.1097/00005344-198507000-00023. J Cardiovasc Pharmacol. 1985. PMID: 2410720 Clinical Trial.

5

Clinical role of direct renin inhibition in hypertension.

Taylor AA, Pool JL. Taylor AA, et al. Among authors: pool jl. Am J Ther. 2012 May;19(3):204-10. doi: 10.1097/MJT.0b013e3182068da5. Am J Ther. 2012. PMID: 21317620

6

Renin-aldosterone profiling in hypertension.

Mitchell JR, Taylor AA, Pool JL, Lake CR, Rollins DE, Bartter FC. Mitchell JR, et al. Among authors: pool jl. Ann Intern Med. 1977 Nov;87(5):596-312. doi: 10.7326/0003-4819-87-5-596. Ann Intern Med. 1977. PMID: 335942 Clinical Trial.

7

Clinical experience and rationale for angiotensin-converting enzyme inhibition with lisinopril as the initial treatment for hypertension in older patients.

Pool JL, Nelson EB, Taylor AA. Pool JL, et al. Am J Med. 1988 Sep 23;85(3B):19-24. doi: 10.1016/0002-9343(88)90345-2. Am J Med. 1988. PMID: 2844082 Review.

8

Terazosin (Hytrin): cumulative experience of clinical trials in the USA for the treatment of mild to moderate essential hypertension.

Pool JL, Nelson EB, Taylor AA, Mitchell JR. Pool JL, et al. Br J Clin Pract Suppl. 1987 Dec;54:9-14. Br J Clin Pract Suppl. 1987. PMID: 2905162 Clinical Trial. No abstract available.

9

Review of the effects of doxazosin, a new selective alpha 1-adrenergic inhibitor, on lipoproteins in patients with essential hypertension.

Pool JL, Taylor AA, Nelson EB. Pool JL, et al. Am J Med. 1989 Aug 16;87(2A):57S-61S. doi: 10.1016/0002-9343(89)90115-0. Am J Med. 1989. PMID: 2569825 Review.

10

Combined terazosin and verapamil therapy in essential hypertension. Hemodynamic and pharmacokinetic interactions.

Lenz ML, Pool JL, Laddu AR, Varghese A, Johnston W, Taylor AA. Lenz ML, et al. Among authors: pool jl. Am J Hypertens. 1995 Feb;8(2):133-45. doi: 10.1016/0895-7061(94)00162-5. Am J Hypertens. 1995. PMID: 7755941 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

218 results

Search Page

Filters